EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Self-Reported and Biologic Assessments of Prenatal Cannabis Use: Ancillary Analysis of a Prospective Observational Cohort

Paulina M Devlin iD, Amanda A Allshouse, Gwen McMillin, Judith H Chung, William A Grobman, David M Haas, Jessica L Pippen, Samuel Parry, Uma M Reddy, George R Saade, Hyagriv N Simhan, Robert M Silver und 1 weitere

Substance Use & Addiction Journal · 2025

DOI: 10.1177/29767342251389751 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Substance Use & Addiction Journal, 2025. Verfasst von Paulina M Devlin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Self Report, Dronabinol, Marijuana Use. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute on Drug Abuse, Clinical and Translational Science Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We evaluated agreement between self-reports of prenatal cannabis use and biologic assays, and identified factors associated with discordance.

Methods

Ancillary analysis of the “Nulliparous Pregnancy Outcomes Study: Monitoring Mothers to Be” (nuMoM2b) study, a United States multicenter prospective cohort of pregnant individuals from October 2010 to September 2013. Past 30-day self-reported prenatal cannabis use was assessed at nuMoM2b study visit 2 (16 weeks and 0 days-21 weeks and 6 days), visit 3 (22 weeks and 0 days-29 weeks and 6 days), and at delivery. Biologic detection of cannabis metabolite (11-nor-9-carboxy-delta-9-tetrahydrocannabinol) was performed with urine samples from visit 2 and visit 3 and the umbilical cord at delivery. The agreement between self-report and biologic assay was evaluated with a Kappa statistic. Factors associated with discordance were evaluated with multivariable logistic regression.

Findings

Nine thousand one hundred sixteen participants were included, and 434 (4.76%) used cannabis by either self-report or biologic assay. Among participants who used cannabis, 74.5% of prenatal cannabis use at visit 2 and 79.6% of prenatal cannabis use at visit 3 was detected via urine assay and not self-report. Eighty-nine point seven percent of prenatal cannabis at delivery use was detected via cord assay and not self-report. The agreement between self-report and biospecimen assay was fair at visit 2 (Kappa 0.30, 95% confidence interval [CI] 0.24-0.36), fair at visit 3 (Kappa 0.23, 95% CI 0.17-0.29), and slight at delivery (Kappa 0.11, 95% CI 0.01-0.21). Age

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Self ReportDronabinolMarijuana UseHumansFemalePregnancyAdultProspective StudiesYoung AdultUnited States

Stichwörter der Autor:innen

cannabishigh-riskmarijuana usepregnancy

Substanzen

Dronabinol

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, UT, USA.
  • ARUP Laboratories, Salt Lake City, UT, USA.
  • Department of Obstetrics and Gynecology, University of California Irvine, Orange, CA, USA.
  • Department of Obstetrics and Gynecology, Brown University, Providence, RI, USA.
  • Department of Obstetrics and Gynecology, Indiana University, Indianapolis, IN, USA.
  • Department of Obstetrics and Gynecology, Case Western Reserve University, Cleveland, OH, USA.

ORCID-Profile: Paulina M Devlin

Förderung

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institute on Drug Abuse
  • Clinical and Translational Science Institute

Zitieren

APA

Devlin, P. M., Allshouse, A. A., McMillin, G., Chung, J. H., Grobman, W. A., Haas, D. M., Pippen, J. L., Parry, S., Reddy, U. M., Saade, G. R., Simhan, H. N., Silver, R. M., & Metz, T. D. (2025). Self-Reported and Biologic Assessments of Prenatal Cannabis Use: Ancillary Analysis of a Prospective Observational Cohort. Substance Use & Addiction Journal. https://doi.org/10.1177/29767342251389751

Vancouver

Devlin PM, Allshouse AA, McMillin G, Chung JH, Grobman WA, Haas DM, et al. Self-Reported and Biologic Assessments of Prenatal Cannabis Use: Ancillary Analysis of a Prospective Observational Cohort. Substance Use & Addiction Journal. 2025. doi:10.1177/29767342251389751

BibTeX
@article{Devlin2025,
  author = {Devlin, Paulina M and Allshouse, Amanda A and McMillin, Gwen and Chung, Judith H and Grobman, William A and Haas, David M and Pippen, Jessica L and Parry, Samuel and Reddy, Uma M and Saade, George R and Simhan, Hyagriv N and Silver, Robert M and Metz, Torri D},
  title = {Self-Reported and Biologic Assessments of Prenatal Cannabis Use: Ancillary Analysis of a Prospective Observational Cohort},
  journal = {Substance Use & Addiction Journal},
  year = {2025},
  doi = {10.1177/29767342251389751}
}
Kostenlos starten →